Company profile

株式会社ＰＲＩＳＭ　ＢｉｏＬａｂ

EDINET
E39751
Securities
206A
Industry
Pharmaceutical
Latest annual securities report
2025-12-24 Annual Securities Report PDF HTML
Latest financial report
2026-05-14 Semiannual Securities Report PDF HTML
Latest filing
—
Compare this company

Industry position

Pharmaceutical

View details
Profitability Above average Current Top 45% 5-year trend Broadly stable
Financial strength Strong Based on Equity ratio Current Top 22% 5-year trend Improving
Growth Very strong Based on Revenue growth Current Top 5%
Cash generation Below average Current Bottom 43% 5-year trend Deteriorating

Latest half-year results

H1 FY2026

2025/10/01 - 2026/03/31

Standalone · Japanese GAAP · Cumulative YTD

For H1 FY2026, revenue was ¥253.21 million, up 15.8% year over year. Operating income was -¥584.86 million, down 27.0% year over year. Net income was -¥603.31 million, down 27.2% year over year.

Revenue ¥253.21M up 15.8% year over year
Operating income -¥584.86M down 27.0% year over year
Net income -¥603.31M down 27.2% year over year
Operating cash flow -¥462.51M
Free cash flow -¥2B
Total assets ¥2.59B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Standalone · Japanese GAAP · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2025

Standalone Japanese GAAP

Revenue reached ¥677.33 million, up 121.6% year over year. Operating income was -¥774.45 million, up 1.0% year over year. Operating margin was -114.3%. Net income was -¥833.7 million, up 20.6% year over year. ROE was -30.8%; equity ratio was 87.6%; free cash flow was -¥1.54 billion.

Revenue ¥677.33M up 121.6% year over year
Operating income -¥774.45M up 1.0% year over year
Net income -¥833.7M up 20.6% year over year
Total assets¥3.09B
Total equity—
Operating cash flow-¥1.47B
Free cash flow-¥1.54B

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Above average

Operating margin Top 45% / ROE Bottom 54%

Financial strength Strong
Based on Equity ratio

Equity ratio Top 25%

Growth Very strong
Based on Revenue growth

Revenue growth Top 10%

Cash generation Below average

Operating cash flow margin Bottom 62% / Free cash flow margin Bottom 62%

Profitability Industry position history Broadly stable
2025 Bottom 28% 2024 Bottom 29%
Financial strength Industry position history Improving
2025 Top 16% 2024 Top 44%
Cash generation Industry position history Deteriorating
2025 Bottom 20% 2024 Top 35%
Profitability Operating margin -114.3% Industry median -155.7% Top 45% Comparison sample 20
Profitability ROE -30.8% Industry median -29.2% Bottom 54% Comparison sample 32
Financial strength Equity ratio 87.6% Industry median 71.4% Top 25% Comparison sample 32
Growth Revenue growth +121.6% Industry median -1.5% Top 10% Comparison sample 21
Cash generation Operating cash flow margin -216.8% Industry median -157.8% Bottom 62% Comparison sample 21
Cash generation Free cash flow margin -227.0% Industry median -167.1% Bottom 62% Comparison sample 21

Annual financial data

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Share price Market cap Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2025 Standalone Japanese GAAP 677330000 -774453000 -748302000 -833700000 3085692000 376862000 2708830000 2701707000 2708830000 -1468363000 -69013000 33588000 -1537376000 2915572000 -22.82 73.4 36810000 0.8778679142 0.876 -0.3077712518 -0.2701825069 -1.1433909616 -1.1047820117 -1.2308623566 -2.1678694285 -2.2697592016 1.2162489366 0.0101470874 0.1000772082 0.2056323212 -0.3186160917 -0.2266895353 -10.7796981564 0.7173764369 -0.9900333971 -15.3475856789 -0.3361663489 0.3194154489 0.0237854195 0.2962962963 0.0533348179 35 9460000
FY2024 Standalone Japanese GAAP 305620000 -782392000 -831518000 -1049514000 4528566000 1025665000 3502901000 3502477000 3502901000 150144000 -244187000 3370055000 -94043000 4392022000 -33.53 97.41 35954800 0.7735121891 0.773 -0.2996128066 -0.2317541579 -2.5600157058 -2.7207578038 -3.4340488188 0.4912767489 -0.3077121916 27 8981000

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp